Jan Heyckendorf

5.1k total citations
55 papers, 1.1k citations indexed

About

Jan Heyckendorf is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Jan Heyckendorf has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 43 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in Jan Heyckendorf's work include Tuberculosis Research and Epidemiology (42 papers), Mycobacterium research and diagnosis (26 papers) and Infectious Diseases and Tuberculosis (19 papers). Jan Heyckendorf is often cited by papers focused on Tuberculosis Research and Epidemiology (42 papers), Mycobacterium research and diagnosis (26 papers) and Infectious Diseases and Tuberculosis (19 papers). Jan Heyckendorf collaborates with scholars based in Germany, Sweden and United States. Jan Heyckendorf's co-authors include Christoph Lange, Dumitru Chesov, Ioana D. Olaru, Morten Rühwald, Keertan Dheda, Chi Chiu Leung, Zarir Udwadia, Novel N. Chegou, Gerhard Walzl and Maja Reimann and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jan Heyckendorf

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Heyckendorf Germany	19	887	703	350	195	97	55	1.1k
Tehmina Mustafa Norway	24	967 1.1×	715 1.0×	635 1.8×	162 0.8×	167 1.7×	82	1.3k
Heping Xiao China	21	670 0.8×	575 0.8×	341 1.0×	148 0.8×	180 1.9×	77	1.2k
Domingo Palmero Argentina	21	855 1.0×	751 1.1×	304 0.9×	166 0.9×	317 3.3×	63	1.2k
Fengmin Huo China	19	908 1.0×	697 1.0×	434 1.2×	224 1.1×	44 0.5×	59	1.2k
Solange Alves Vinhas Brazil	17	727 0.8×	682 1.0×	280 0.8×	112 0.6×	91 0.9×	37	990
Giorgio Besozzi Italy	17	785 0.9×	612 0.9×	316 0.9×	179 0.9×	72 0.7×	43	971
Seung Kyu Park South Korea	11	649 0.7×	498 0.7×	276 0.8×	192 1.0×	110 1.1×	38	945
Mamoudou Maïga United States	21	758 0.9×	609 0.9×	203 0.6×	372 1.9×	95 1.0×	78	1.2k
Shinji Maeda Japan	19	840 0.9×	961 1.4×	509 1.5×	195 1.0×	87 0.9×	71	1.3k
Sunali Goonesekera United States	11	841 0.9×	707 1.0×	382 1.1×	288 1.5×	168 1.7×	17	1.3k

Countries citing papers authored by Jan Heyckendorf

Since Specialization

Citations

This map shows the geographic impact of Jan Heyckendorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Heyckendorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Heyckendorf more than expected).

Fields of papers citing papers by Jan Heyckendorf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Heyckendorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Heyckendorf. The network helps show where Jan Heyckendorf may publish in the future.

Co-authorship network of co-authors of Jan Heyckendorf

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Heyckendorf. A scholar is included among the top collaborators of Jan Heyckendorf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Heyckendorf. Jan Heyckendorf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reimann, Maja, Dumitru Chesov, Alexandra Hölscher, et al.. (2024). The molecular bacterial load assay predicts treatment responses in patients with pre-XDR/XDR-tuberculosis more accurately than GeneXpert Ultra MTB/Rif. Journal of Infection. 90(2). 106399–106399. 2 indexed citations

Ramachandran, Rekha, Andreea Dumitrescu, Beatrice Mahler, et al.. (2024). Impact of drug-resistant tuberculosis on socio-economic status, quality of life and psychological well-being of patients in Bucharest, Romania: a prospective cohort study. Journal of Health Population and Nutrition. 43(1). 223–223. 3 indexed citations

Diacon, Andreas H., Clifton E. Barry, Ray Y. Chen, et al.. (2024). A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nature Medicine. 30(3). 896–904. 20 indexed citations

Gillespie, Stephen H., Andrew R. DiNardo, Sophia B. Georghiou, et al.. (2024). Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles. The Lancet Microbe. 5(9). 100869–100869. 3 indexed citations

Otto-Knapp, Ralf, Torsten T. Bauer, Folke Brinkmann, et al.. (2024). Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland. Respiration. 103(9). 593–600. 1 indexed citations

DiNardo, Andrew R., Jan Heyckendorf, Sandra L. Grimm, et al.. (2022). Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes. European Respiratory Journal. 60(3). 2102263–2102263. 22 indexed citations

Heyckendorf, Jan, Sophia B. Georghiou, Nicole Frahm, et al.. (2022). Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies. Clinical Microbiology Reviews. 35(3). 44 indexed citations

Rohmann, Nathalie, Corinna Geisler, Kristina Schlicht, et al.. (2022). Brief Research Report: Serum clara cell 16 kDa protein levels are increased in patients hospitalized for severe SARS-CoV-2 or sepsis infection. Frontiers in Immunology. 13. 1037115–1037115. 5 indexed citations

DiNardo, Andrew R., Tomoki Nishiguchi, Sandra L. Grimm, et al.. (2021). Tuberculosis endotypes to guide stratified host-directed therapy. Med. 2(3). 217–232. 24 indexed citations

10.

Kontsevaya, Irina, Christoph Lange, Cristian Coarfa, et al.. (2021). Perspectives for systems biology in the management of tuberculosis. European Respiratory Review. 30(160). 200377–200377. 16 indexed citations

11.

Heyckendorf, Jan, Stephen H. Gillespie, & Morten Rühwald. (2020). Culture-free proof of Mycobacterium tuberculosis - a new assay for viable bacteria. EBioMedicine. 62. 103117–103117. 5 indexed citations

12.

Salzer, Helmut J.F., Christiane Kuempers, Helen Pasternack, et al.. (2018). An Unexpected Endobronchial Mass Appearing During Bronchoscopy. CHEST Journal. 154(1). e13–e21. 1 indexed citations

13.

Heyckendorf, Jan, Lize van der Merwe, Patricia Sanchez‐Carballo, et al.. (2018). Mycobacterium Growth Inhibition Assay of Human Alveolar Macrophages as a Correlate of Immune Protection Following Mycobacterium bovis Bacille Calmette–Guérin Vaccination. Frontiers in Immunology. 9. 1708–1708. 5 indexed citations

14.

Heyckendorf, Jan, Sönke Andres, Claudio U. Köser, et al.. (2017). What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy. 62(2). 80 indexed citations

15.

Parida, Shreemanta K., Thomas Poiret, Zhenjiang Liu, et al.. (2015). T-Cell Therapy: Options for Infectious Diseases: Table 1.. Clinical Infectious Diseases. 61(suppl 3). S217–S224. 40 indexed citations

16.

Blauenfeldt, Thomas, Dirk Wagner, Martine G. Aabye, et al.. (2015). Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study. Tuberculosis. 98. 7–12. 7 indexed citations

17.

Harbaum, Lars, Jasmin Wellbrock, Jan K. Hennigs, et al.. (2014). M2 macrophages derived from patients with idiopathic pulmonary arterial hypertension are susceptible for apelin-mediated suppression of pro-inflammatory cytokines. European Respiratory Journal. 44(Suppl 58). P311–P311.

18.

Heyckendorf, Jan, Ioana D. Olaru, Morten Rühwald, & Christoph Lange. (2014). Getting Personal Perspectives on Individualized Treatment Duration in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 190(4). 374–383. 26 indexed citations

19.

Hennigs, Jan K., Hans Jörg Baumann, Nicole Lüneburg, et al.. (2014). Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertension. Scientific Reports. 4(1). 4808–4808. 17 indexed citations

20.

Chegou, Novel N., Jan Heyckendorf, Gerhard Walzl, Christoph Lange, & Morten Rühwald. (2013). Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection withMycobacterium tuberculosis. European Respiratory Journal. 43(5). 1472–1486. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact